Dabrafenib in Treating Patients With Solid Tumors and Kidney or Liver Dysfunction

Summary

This phase I trial studies the side effects and best dose of dabrafenib in treating patients with solid tumors and kidney or liver dysfunction. Dabrafenib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.

Timeline

Start

2013-08-23

Primary completion

2015-12-16

Completion

2015-12-16

Drugs

Indications